BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 24056537)

  • 21. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
    Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders.
    Gallea C; Ewenczyk C; Degos B; Welter ML; Grabli D; Leu-Semenescu S; Valabregue R; Berroir P; Yahia-Cherif L; Bertasi E; Fernandez-Vidal S; Bardinet E; Roze E; Benali H; Poupon C; François C; Arnulf I; Lehéricy S; Vidailhet M
    Mov Disord; 2017 May; 32(5):693-704. PubMed ID: 28164375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
    Liu SY; Wile DJ; Fu JF; Valerio J; Shahinfard E; McCormick S; Mabrouk R; Vafai N; McKenzie J; Neilson N; Perez-Soriano A; Arena JE; Cherkasova M; Chan P; Zhang J; Zabetian CP; Aasly JO; Wszolek ZK; McKeown MJ; Adam MJ; Ruth TJ; Schulzer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2018 Apr; 17(4):309-316. PubMed ID: 29456161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postural instability and cognitive dysfunction in early Parkinson's disease.
    Lee JM; Koh SB; Chae SW; Seo WK; Kwon DY; Kim JH; Oh K; Baik JS; Park KW
    Can J Neurol Sci; 2012 Jul; 39(4):473-82. PubMed ID: 22728854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
    Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
    Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease.
    Craig CE; Jenkinson NJ; Brittain JS; Grothe MJ; Rochester L; Silverdale M; Alho ATDL; Alho EJL; Holmes PS; Ray NJ
    Mov Disord; 2020 Jul; 35(7):1199-1207. PubMed ID: 32400071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic system changes of falls and freezing of gait in Parkinson's disease.
    Bohnen NI; Kanel P; Zhou Z; Koeppe RA; Frey KA; Dauer WT; Albin RL; Müller MLTM
    Ann Neurol; 2019 Apr; 85(4):538-549. PubMed ID: 30720884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults.
    Cham R; Perera S; Studenski SA; Bohnen NI
    Gait Posture; 2007 Oct; 26(4):516-25. PubMed ID: 17196819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.
    Bohnen NI; Kanel P; Koeppe RA; Sanchez-Catasus CA; Frey KA; Scott P; Constantine GM; Albin RL; Müller MLTM
    Brain Commun; 2021; 3(2):fcab109. PubMed ID: 34704022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cholinergic systems' changes in progressive supranuclear palsy versus Parkinson's disease: an exploratory analysis.
    Kanel P; Spears CC; Roytman S; Koeppe RA; Frey KA; Scott PJH; Albin RL; Bohnen NI
    J Neural Transm (Vienna); 2022 Dec; 129(12):1469-1479. PubMed ID: 36222971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.
    Albin RL; van der Zee S; van Laar T; Sarter M; Lustig C; Muller MLTM; Bohnen NI
    Prog Brain Res; 2022; 269(1):345-371. PubMed ID: 35248201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
    Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
    Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.
    Kim K; Müller MLTM; Bohnen NI; Sarter M; Lustig C
    Neuroimage; 2017 Apr; 149():295-304. PubMed ID: 28167350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
    Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
    Müller ML; Frey KA; Petrou M; Kotagal V; Koeppe RA; Albin RL; Bohnen NI
    Mov Disord; 2013 Mar; 28(3):296-301. PubMed ID: 23239424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET imaging with [¹⁸F]fluoroethoxybenzovesamicol ([¹⁸F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat.
    Cyr M; Parent MJ; Mechawar N; Rosa-Neto P; Soucy JP; Aliaga A; Kostikov A; Maclaren DA; Clark SD; Bedard MA
    Nucl Med Biol; 2014 Jan; 41(1):96-101. PubMed ID: 24267056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.